|By Marketwired .||
|November 22, 2012 08:45 AM EST||
NEW YORK, NY -- (Marketwire) -- 11/22/12 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.
Amarin Corporation plc (NASDAQ: AMRN) shares of the late-stage biopharmaceutical company surged 8 percent Wednesday after reporting it has received a patent covering Amarin's Vascepa (icosapent ethyl) capsules.
Find out more about Amarin including full access to the free equity report at: www.BedfordReport.com/AMRN
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares of the anti-obesity drug maker received a boost Wednesday after the third-largest health insurer, Aetna, stated it would provide coverage for Vivus' and Arena's diet drugs.
Find out more about Arena Pharmaceuticals including full access to the free equity report at: www.BedfordReport.com/ARNA
Complete Genomics, Inc. (NASDAQ: GNOM) BGI-Shenzhen has extended its deadline for its tender offer to acquire the company to December 14. It has recently been reported that Illumina Inc. was the second company to make a competing bid.
Find out more about Complete Genomics including full access to the free equity report at: www.BedfordReport.com/GNOM
Sequenom, Inc. (NASDAQ: SQNM) shares of the molecular diagnostic testing and genetics analysis company surged Wednesday after American College of Obstetricians and Gynecologists recommended cell-free fetal DNA testing be offered to patients.
Find out more about Sequenom including full access to the free equity report at: www.BedfordReport.com/SQNM
Disclaimer: Equity News Circuit is not a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security. A third party, bedfordreport.com has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release.
Equity News Circuit